The Epidemiology of Childhood Leukemia with a Focus on Birth Weight and Diet

REFERENCES

• Canadian Cancer Statistics 2006, J McLaughlin, D Dryer, H Logan, Y Mao, L Marrett, H Morrison, B Schacter, G Villeneuve, C Waters, R Semenciw. National Cancer Institute of Canada, Toronto 2006
   Google Scholar
• SEER Cancer Statistics Review, 1975-2002, L AG Ries, M P Eisner, C L Kosary, B F Hankey, B A Miller, L Clegg, A Mariotto, E J Feuer, B K Edwards. National Cancer Institute, Bethesda, MD 2003
   Google Scholar
• Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995, L A Ries, M A Smith, J G Gurney, M Linet, T Tamra, J L Young, G R Bunin. National Cancer Institute, SEER Program, Bethesda, MD 1999
   Google Scholar
• Smith M A, Chen T, Simon R. Age-specific incidence of acute lymphoblastic leukemia in U.S. children: In utero initiation model. J Natl Cancer Inst 1997; 89: 1542–1544
   PubMed Web of Science ®Google Scholar
• Greaves M F. Childhood leukaemia. BMJ 2002; 324: 283–287
   PubMed Web of Science ®Google Scholar
• Greaves M, Maia A T, Wiemels J L, Ford A M. Leukemia in twins: lessons in natural history. Blood 2003; 102: 2321–2333
   PubMed Web of Science ®Google Scholar
• International Incidence of Childhood Cancer, Volume II. International Agency for Research on Cancer, LyonFrance 1998
   Google Scholar
• Margolin J F, Steuber C P, Poplack D G. Acute lymphoblastic leukemia. Principles and Practice of Pediatric Oncology, 4th Ed, D G Poplack, P A Pizzo. Lippincott Williams & Wilkins, Philadelphia 2002; 489–544
   Google Scholar
• Golub T, Arceci R. Acute myelogenous leukemia. Principles and Practice of Pediatric Oncology, 4th Ed., D G Poplack, P A Pizzo. Lippincott Williams & Wilkins, Philadelphia 2002; 545–590
   Google Scholar
• Wiemels J L, Zhang Y, Chang J, Zheng S, Metayer C, Zhang L, Smith M T, Ma X, Selvin S, Buffler P A, Wiencke J K. RAS mutation is associated with hyperdiploidy and parental characteristics in pediatric acute lymphoblastic leukemia. Leukemia 2005; 19: 415–419
   PubMed Web of Science ®Google Scholar
• Spector L G, Xie Y, Robison L L, Heerema N A, Hilden J M, Lange B, Felix C A, Davies S M, Slavin J, Potter J D, Blair C K, Reaman G H, Ross J A. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: A report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev 2005; 14: 651–655
   PubMed Web of Science ®Google Scholar
• Buckley J D, Buckley C M, Ruccione K, Sather H N, Waskerwitz M J, Woods W G, Robison L L. Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer Group. Leukemia 1994; 8: 856–864
   PubMed Web of Science ®Google Scholar
• Davies S M, Robison L L, Buckley J D, Radloff G A, Ross J A, Perentesis J P. Glutathione S-transferase polymorphisms in children with myeloid leukemia: a Children's Cancer Group study. Cancer Epidemiol Biomarkers Prev 2000; 9: 563–566
   PubMed Web of Science ®Google Scholar
• Rothman K J, Greenland S. Case-control studies. Modern Epidemiology, 2d Ed, K J Rothman, S Greenland. Lippincott-Raven, Philadelphia 1998; 93–114
   Google Scholar
• Mezei G, Kheifets L. Selection bias and its implications for case-control studies: a case study of magnetic field exposure and childhood leukaemia. Int J Epidemiol 2006; 35: 397–406
   PubMed Web of Science ®Google Scholar
• Raaschou-Nielsen O, Reynolds P. Air pollution and childhood cancer: A review of the epidemiological literature. Int J Cancer 2006; 118: 2920–2929
   PubMed Web of Science ®Google Scholar
• Kwan M L, Buffler P A, Abrams B, Kiley V A. Breastfeeding and the risk of childhood leukemia: a meta-analysis. Public Health Rep 2004; 119: 521–535
   PubMed Web of Science ®Google Scholar
• Guise J M, Austin D, Morris C D. Review of case-control studies related to breastfeeding and reduced risk of childhood leukemia. Pediatrics 2005; 116: e724–e731
   Google Scholar
• Wartenberg D. Residential EMF exposure and childhood leukemia: meta-analysis and population attributable risk. Bioelectromagnetics 2001; S86–104, Suppl 5
   Google Scholar
• Kheifets L, Shimkhada R. Childhood leukemia and EMF: review of the epidemiologic evidence. Bioelectromagnetics 2005; S51–59, Suppl 7
   Google Scholar
• McNally R J, Eden T O. An infectious aetiology for childhood acute leukaemia: a review of the evidence. Br J Haematol 2004; 127: 243–263
   PubMed Web of Science ®Google Scholar
• Stiller C A. Epidemiology and genetics of childhood cancer. Oncogene 2004; 23: 6429–6444
   PubMed Web of Science ®Google Scholar
• Dorak M T, Burnett A K, Worwood M. HFE gene mutations in susceptibility to childhood leukemia: HuGE review. Genet Med 2005; 7: 159–168
   PubMed Web of Science ®Google Scholar
• Sinnett D, Labuda D, Krajinovic M. Challenges identifying genetic determinants of pediatric cancers—the childhood leukemia experience. Fam Cancer 2006; 5: 35–47
   PubMed Web of Science ®Google Scholar
• Roman E, Fear N T, Ansell P, Bull D, Draper G, McKinney P, Michaelis J, Passmore S J, von Kries R. Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. Br J Cancer 2002; 86: 63–69
   PubMed Web of Science ®Google Scholar
• Laurier D, Grosche B, Hall P. Risk of childhood leukaemia in the vicinity of nuclear installations—findings and recent controversies. Acta Oncologica 2002; 41: 14–24
   PubMed Web of Science ®Google Scholar
• Poole C, Greenland S, Luetters C, Kelsey J L, Mezei G. Socioeconomic status and childhood leukaemia: A review. Int J Epidemiol 2006; 35: 370–384
   PubMed Web of Science ®Google Scholar
• Greaves M F, Pegram S M, Chan L C. Collaborative group study of the epidemiology of acute lymphoblastic leukaemia subtypes: Background and first report. Leuk Res 1985; 9: 715–733
   PubMed Web of Science ®Google Scholar
• Greaves M F, Colman S M, Beard M E, Bradstock K, Cabrera M E, Chen P M, Jacobs P, Lam-Po-Tang P R, MacDougall L G, Williams C K, Alexander F E. Geographical distribution of acute lymphoblastic leukaemia subtypes: second report of the collaborative group study. Leukemia 1993; 7: 27–34
   PubMed Web of Science ®Google Scholar
• Gurney J G, Severson R K, Davis S, Robison L L. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995; 75: 2186–2195
   PubMed Web of Science ®Google Scholar
• Heston J F, Kelly J B, Meigs J W, Flannery J T. Forty-Five Years of Cancer Incidence in Connecticut: 1935–1979. National Cancer Institute, Bethesda, MD 1986
   Google Scholar
• Court Brown W M, Doll R. Leukaemia in childhood and young adult life. BMJ 1961; 981–988
   PubMedGoogle Scholar
• Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, Sultan C. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 1981; 47: 553–561
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620–625
   PubMed Web of Science ®Google Scholar
• Viana M B, Maurer H S, Ferenc C. Subclassification of acute lymphoblastic leukaemia in children: analysis of the reproducibility of morphological criteria and prognostic implications. Br J Haemetol 1980; 44: 383–388
   PubMedGoogle Scholar
• Miller D R, Leikin S, Albo V, Sather H, Hammond D. Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL). Br J Haemetol 1981; 48: 199–206
   PubMed Web of Science ®Google Scholar
• Lilleyman J S, Hann I M, Stevens R F. The clinical significance of blast cell morphology in childhood lymphoblastic leukaemia. Med Pediatr Oncol 1986; 14: 144–147
   PubMedGoogle Scholar
• Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down's syndrome: a review. Pediatr Hematol Oncol 1987; 4: 211–230
   PubMed Web of Science ®Google Scholar
• Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia 1996; 10: 877–895
   PubMed Web of Science ®Google Scholar
• Pui C H, Behm F G, Crist W M. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 343–362
   PubMed Web of Science ®Google Scholar
• Rubnitz J E, Look A T. Molecular genetics of childhood leukemias. J Pediatr Hematol Oncol 1998; 20: 1–11
   PubMed Web of Science ®Google Scholar
• Greaves M F, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003; 3: 639–649
   PubMed Web of Science ®Google Scholar
• Shurtleff S A, Buijs A, Behm F G, Rubnitz J E, Raimondi S C, Hancock M L, Chan G C, Pui C H, Grosveld G, Downing J R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985–1989
   PubMed Web of Science ®Google Scholar
• Aldrich M C, Zhang L, Wiemels J L, Ma X, Loh M L, Metayer C, Selvin S, Feusner J, Smith M T, Buffler P A. Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California. Cancer Epidemiol Biomarkers Prev 2006; 15: 578–581
   PubMed Web of Science ®Google Scholar
• Kempski H, Mensa-Bonsu K A, Kearney L, Jalali G R, Hann I, Khurshid M, Greaves M F. Prenatal chromosomal diversification of leukemia in monozygotic twins. Genes Chromosomes Cancer 2003; 37: 406–411
   PubMed Web of Science ®Google Scholar
• Daley G Q, McLaughlin J, Witte O N, Baltimore D. The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science 1987; 237: 532–535
   PubMed Web of Science ®Google Scholar
• Daley G Q, Baltimore D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci USA 1988; 85: 9312–9316
   PubMed Web of Science ®Google Scholar
• Castellanos A, Pintado B, Weruaga E, Arevalo R, Lopez A, Orfao A, Sanchez-Garcia I. A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood 1997; 90: 2168–2174
   PubMed Web of Science ®Google Scholar
• Crist W M, Carroll A J, Shuster J J, Behm F G, Whitehead M, Vietti T J, Look A T, Mahoney D, Ragab A, Pullen D J, et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood 1990; 76: 117–122
   PubMed Web of Science ®Google Scholar
• Raimondi S C, Behm F G, Roberson P K, Williams D L, Pui C H, Crist W M, Look A T, Rivera G K. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J Clin Oncol 1990; 8: 1380–1388
   PubMed Web of Science ®Google Scholar
• Lampert F, Harbott J, Ritterbach J, Schellong G, Ritter J, Creutzig U, Riehm H, Reiter A. Karyotypes in acute childhood leukemias may lose prognostic significance with more intensive and specific chemotherapy. Cancer Genet Cytogenet 1991; 54: 277–279
   PubMedGoogle Scholar
• Secker-Walker L M, Berger R, Fenaux P, Lai J L, Nelken B, Garson M, Michael P M, Hagemeijer A, Harrison C J, Kaneko Y, et al. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 1992; 6: 363–369
   PubMed Web of Science ®Google Scholar
• Uckun F M, Nachman J B, Sather H N, Sensel M G, Kraft P, Steinherz P G, Lange B, Hutchinson R, Reaman G H, Gaynon P S, Heerema N A. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. Cancer 1998; 83: 2030–2039
   PubMed Web of Science ®Google Scholar
• Shima E A, Le Beau M M, McKeithan T W, Minowada J, Showe L C, Mak T W, Minden M D, Rowley J D, Diaz M O. Gene encoding the alpha chain of the T-cell receptor is moved immediately downstream of c-myc in a chromosomal 8;14 translocation in a cell line from a human T-cell leukemia. Proc Natl Acad Sci USA 1986; 83: 3439–3443
   PubMedGoogle Scholar
• McKeithan T W, Shima E A, Le Beau M M, Minowada J, Rowley J D, Diaz M O. Molecular cloning of the breakpoint junction of a human chromosomal 8;14 translocation involving the T-cell receptor alpha-chain gene and sequences on the 3′ side of MYC. Proc Natl Acad Sci USA 1986; 83: 6636–6640
   PubMed Web of Science ®Google Scholar
• Begley C G, Aplan P D, Davey M P, Nakahara K, Tchorz K, Kurtzberg J, Hershfield M S, Haynes B F, Cohen D I, Waldmann T A, et al. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci USA 1989; 86: 2031–2035
   PubMed Web of Science ®Google Scholar
• Chen Q, Cheng J T, Tasi L H, Schneider N, Buchanan G, Carroll A, Crist W, Ozanne B, Siciliano M J, Baer R. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 1990; 9: 415–424
   PubMed Web of Science ®Google Scholar
• Heerema N A, Nachman J B, Sather H N, Sensel M G, Lee M K, Hutchinson R, Lange B J, Steinherz P G, Bostrom B, Gaynon P S, Uckun F. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. Blood 1999; 94: 4036–4045
   PubMed Web of Science ®Google Scholar
• Heerema N A, Sather H N, Sensel M G, Zhang T, Hutchinson R J, Nachman J B, Lange B J, Steinherz P G, Bostrom B C, Reaman G H, Gaynon P S, Uckun F M. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes). J Clin Oncol 2000; 18: 1876–1887
   PubMed Web of Science ®Google Scholar
• Trueworthy R, Shuster J, Look T, Crist W, Borowitz M, Carroll A, Frankel L, Harris M, Wagner H, Haggard M, et al. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 1992; 10: 606–613
   PubMed Web of Science ®Google Scholar
• Harris M B, Shuster J J, Carroll A, Look A T, Borowitz M J, Crist W M, Nitschke R, Pullen J, Steuber C P, Land V J. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood 1992; 79: 3316–3324
   PubMed Web of Science ®Google Scholar
• Wolman I J. Parallel responses to chemotherapy in identical twin infants with concordant leukemia. J Pediatr 1962; 60: 91–95
   PubMedGoogle Scholar
• van Dijk B A, Boomsma D I, de Man A J. Blood group chimerism in human multiple births is not rare. Am J Med Genet 1996; 61: 264–268
   PubMed Web of Science ®Google Scholar
• Greaves M. In utero origins of childhood leukaemia. Early Hum Dev 2005; 81: 123–29
   PubMed Web of Science ®Google Scholar
• Greaves M F, Maia A T, Wiemels J L, Ford A M. Leukemia in twins: lessons in natural history. Blood 2003; 102: 2321–2333
   PubMed Web of Science ®Google Scholar
• Gale K B, Ford A M, Repp R, Borkhardt A, Keller C, Eden O B, Greaves M F. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997; 94: 13950–1395
   PubMed Web of Science ®Google Scholar
• Wiemels J L, Cazzaniga G, Daniotti M, Addison G M, Masera G, Saha V, Biondi A, Greaves M F. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 1999; 354: 1499–503
   PubMed Web of Science ®Google Scholar
• Fasching K, Panzer S, Haas O A, Marschalek R, Gadner H, Panzer-Grumayer E R. Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia. Blood 2000; 95: 2722–2724
   PubMed Web of Science ®Google Scholar
• Yagi T, Hibi S, Tabata Y, Kuriyama K, Teramura T, Hashida T, Shimizu Y, Takimoto T, Todo S, Sawada T, Imashuku S. Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood 2000; 96: 264–268
   PubMed Web of Science ®Google Scholar
• Hjalgrim L L, Madsen H O, Melbye M, Jorgensen P, Christiansen M, Andersen M T, Pallisgaard N, Hokland P, Clausen N, Ryder L P, Schmiegelow K, Hjalgrim H. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer 2002; 87: 994–999
   PubMed Web of Science ®Google Scholar
• Taub J W, Konrad M A, Ge Y, Naber J M, Scott J S, Matherly L H, Ravindranath Y. High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood 2002; 99: 2992–2996
   PubMed Web of Science ®Google Scholar
• Wiemels J L, Leonard B C, Wang Y, Segal M R, Hunger S P, Smith M T, Crouse V, Ma X, Buffler P A, Pine S R. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2002; 99: 15101–15106
   PubMed Web of Science ®Google Scholar
• Wiemels J L, Xiao Z, Buffler P A, Maia A T, Ma X, Dicks B M, Smith M T, Zhang L, Feusner J, Wiencke J, Pritchard-Jones K, Kempski H, Greaves M. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 2002; 99: 3801–3805
   PubMed Web of Science ®Google Scholar
• Panzer-Grumayer E R, Fasching K, Panzer S, Hettinger K, Schmitt K, Stockler-Ipsiroglu S, Haas O A. Nondisjunction of chromosomes leading to hyperdiploid childhood B-cell precursor acute lymphoblastic leukemia is an early event during leukemogenesis. Blood 2002; 100: 347–349
   PubMed Web of Science ®Google Scholar
• McHale C M, Wiemels J L, Zhang L, Ma X, Buffler P A, Guo W, Loh M L, Smith M T. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California. Genes Chromosomes Cancer 2003; 37: 36–43
   PubMed Web of Science ®Google Scholar
• McHale C M, Wiemels J L, Zhang L, Ma X, Buffler P A, Feusner J, Matthay K, Dahl G, Smith M T. Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16). Blood 2003; 101: 4640–4641
   PubMed Web of Science ®Google Scholar
• Maia A T, Koechling J, Corbett R, Metzler M, Wiemels J L, Greaves M. Protracted postnatal natural histories in childhood leukemia. Genes Chromosomes Cancer 2004; 39: 335–340
   PubMed Web of Science ®Google Scholar
• Maia A T, Tussiwand R, Cazzaniga G, Rebulla P, Colman S, Biondi A, Greaves M. Identification of preleukemic precursors of hyperdiploid acute lymphoblastic leukemia in cord blood. Genes Chromosomes Cancer 2004; 40: 38–43
   PubMed Web of Science ®Google Scholar
• Mori H, Colman S M, Xiao Z, Ford A M, Healy L E, Donaldson C, Hows J M, Navarrete C, Greaves M. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 2002; 99: 8242–8247
   PubMed Web of Science ®Google Scholar
• Schoen R E, Weissfeld J L, Kuller L H, Thaete F L, Evans R W, Hayes R B, Rosen C J. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 2005; 129: 464–475
   PubMed Web of Science ®Google Scholar
• Murray L, Watson P, Johnston B, Sloan J, Mainie I M, Gavin A. Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ 2003; 327: 534–535
   PubMed Web of Science ®Google Scholar
• Ravetto P F, Agarwal R, Chiswick M L, D'Souza S W, Eden O B, Taylor G M. Absence of leukaemic fusion gene transcripts in preterm infants exposed to diagnostic x rays. Arch Dis Child Fetal Neonatal Ed 2003; 88: F237–F244
   Google Scholar
• Anderson L M, Diwan B A, Fear N T, Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. Environ Health Perspect 2000; 108: 573–594, Suppl 3
   PubMed Web of Science ®Google Scholar
• Liu L, Krailo M, Reaman G H, Bernstein L. Childhood cancer patients' access to cooperative group cancer programs: a population-based study. Cancer 2003; 97: 1339–1345
   PubMed Web of Science ®Google Scholar
• Ross J A, Severson R K, Pollock B H, Robison L L. Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer 1996; 77: 201–207
   PubMedGoogle Scholar
• Heath C W, Jr. Community clusters of childhood leukemia and lymphoma: evidence of infection?. Am J Epidemiol 2005; 162: 817–822
   PubMedGoogle Scholar
• Law G R. Invited commentary: Do clusters of leukemia and lymphoma provide evidence for an infectious cause?. Am J Epidemiol 2005; 162: 823–824
   PubMedGoogle Scholar
• Grufferman S. Methodologic approaches to studying environmental factors in childhood cancer. Environ Health Perspec. 1998; 106: 881–886, Suppl 3
   PubMedGoogle Scholar
• Reynolds P, Smith D F, Satariano E, Nelson D O, Goldman L R, Neutra R R. The four county study of childhood cancer: clusters in context. Stat Med 1996; 15: 683–697
   PubMedGoogle Scholar
• Alexander F. Clustering of childhood acute leukaemia: The EUROCLUS Project. Radiat Environ Biophys 1998; 37: 71–74
   PubMedGoogle Scholar
• Alexander F E, Boyle P, Carli P M, Coebergh J W, Draper G J, Ekbom A, Levi F, McKinney P A, McWhirter W, Magnani C, Michaelis J, Olsen J H, Peris-Bonet R, Petridou E, Pukkala E, Vatten L. Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer 1998; 77: 812–817
   PubMed Web of Science ®Google Scholar
• Alexander F E, Boyle P, Carli P M, Coebergh J W, Draper G J, Ekbom A, Levi F, McKinney P A, McWhirter W, Michaelis J, Peris-Bonet R, Petridou E, Pompe-Kirn V, Plisko I, Pukkala E, Rahu M, Storm H, Terracini B, Vatten L, Wray N. Spatial clustering of childhood leukaemia: summary results from the EUROCLUS project. Br J Cancer 1998; 77: 818–824
   PubMedGoogle Scholar
• Steinmaus C, Lu M, Todd R L, Smith A H. Probability estimates for the unique childhood leukemia cluster in Fallon, Nevada, and risks near other U.S. military aviation facilities. Environ Health Perspect 2004; 112: 766–771
   PubMed Web of Science ®Google Scholar
• Rothman K J, Greenland S. Cohort studies. Modern Epidemiology, 2nd Ed, K J Rothman, S Greenland. Lippincott-Raven, Philadelphia 1998; 79–91
   Google Scholar
• Westergaard T, Andersen P K, Pedersen J B, Olsen J H, Frisch M, Sorensen H T, Wohlfahrt J, Melbye M. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 1997; 89: 939–947
   PubMedGoogle Scholar
• Murray L, McCarron P, Bailie K, Middleton R, Davey Smith G, Dempsey S, McCarthy A, Gavin A. Association of early life factors and acute lymphoblastic leukaemia in childhood: historical cohort study. Br J Cancer 2002; 86: 356–361
   PubMed Web of Science ®Google Scholar
• Paltiel O, Harlap S, Deutsch L, Knaanie A, Massalha S, Tiram E, Barchana M, Friedlander Y. Birth weight and other risk factors for acute leukemia in the Jerusalem Perinatal Study cohort. Cancer Epidemiol Biomarkers Prev 2004; 13: 1057–1064
   PubMed Web of Science ®Google Scholar
• Mucci L A, Granath F, Cnattingius S. Maternal smoking and childhood leukemia and lymphoma risk among 1,440,542 Swedish children. Cancer Epidemiol Biomarkers Prev 2004; 13: 1528–1533
   PubMedGoogle Scholar
• Wacholder S, McLaughlin J K, Silverman D T, Mandel J S. Selection of controls in case-control studies. I. Principles. Am J Epidemiol 1992; 135: 1019–1028
   PubMed Web of Science ®Google Scholar
• Wacholder S, Silverman D T, McLaughlin J K, Mandel J S. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992; 135: 1029–1041
   PubMed Web of Science ®Google Scholar
• Wacholder S, Silverman D T, McLaughlin J K, Mandel J S. Selection of controls in case-control studies. III. Design options. Am J Epidemiol 1992; 135: 1042–1050
   PubMed Web of Science ®Google Scholar
• Neglia J P, Linet M S, Shu X O, Severson R K, Potter J D, Mertens A C, Wen W, Kersey J H, Robison L L. Patterns of infection and day care utilization and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2000; 82: 234–240
   PubMed Web of Science ®Google Scholar
• Ross J A, Olshan A F. Pediatric cancer in the United States: the Children's Oncology Group Epidemiology Research Program. Cancer Epidemiol Biomarkers Prev 2004; 13: 1552–1554
   PubMed Web of Science ®Google Scholar
• Ma X, Buffler P A, Selvin S, Matthay K K, Wiencke J K, Wiemels J L, Reynolds P. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer 2002; 86: 1419–1424
   PubMed Web of Science ®Google Scholar
• Infante-Rivard C. Diagnostic x rays, DNA repair genes and childhood acute lymphoblastic leukemia. Health Phys 2003; 85: 60–64
   PubMed Web of Science ®Google Scholar
• Ma X, Metayer C, Does M B, Buffler P A. Maternal pregnancy loss, birth characteristics, and childhood leukemia (United States). Cancer Causes Control 2005; 16: 1075–1083
   PubMedGoogle Scholar
• Robison L L, Daigle A. Control selection using random digit dialing for cases of childhood cancer. Am J Epidemiol 1984; 120: 164–166
   PubMedGoogle Scholar
• Ross J A, Spector L G, Olshan A F, Bunin G R. Invited commentary: birth certificates—a best control scenario?. Am J Epidemiol 2004; 159: 922–924, discussion 925
   PubMed Web of Science ®Google Scholar
• Ma X, Buffler P A, Layefsky M, Does M B, Reynolds P. Control selection strategies in case-control studies of childhood diseases. Am J Epidemiol 2004; 159: 915–921
   PubMed Web of Science ®Google Scholar
• Gilboa S M, Mendola P, Olshan A F, Savitz D A, Herring A H, Loomis D, Langlois P H, Keating K. Characteristics that predict locating and interviewing mothers identified by a state birth defects registry and vital records. Birth Defects Res A Clin Mol Teratol 2006; 76: 60–65
   PubMedGoogle Scholar
• Spector L G, Unpublished observations
   Google Scholar
• Bunin G R, Gyllstrom M E, Brown J E, Kahn E B, Kushi L H. Recall of diet during a past pregnancy. Am J Epidemiol 2001; 154: 1136–1142
   PubMed Web of Science ®Google Scholar
• Schuz J, Spector L G, Ross J A. Bias in studies of parental self-reported occupational exposure and childhood cancer. Am J Epidemiol 2003; 158: 710–716
   PubMed Web of Science ®Google Scholar
• Ruccione K S, Waskerwitz M, Buckley J, Perin G, Hammond G D. What caused my child's cancer? Parents' responses to an epidemiology study of childhood cancer. J Pediatr Oncol Nurs 1994; 11: 71–84
   PubMedGoogle Scholar
• Trivers K F, Mertens A C, Ross J A, Steinbuch M, Olshan A F, Robison L L. Parental marijuana use and risk of childhood acute myeloid leukaemia: a report from the Children's Cancer Group (United States and Canada). Paediatr Perinat Epidemiol 2006; 20: 110–118
   PubMedGoogle Scholar
• Spector L, Groves F, DeStefano F, Liff J, Klein M, Mullooly J, Black S, Shinefield H, Ward J, Marcy M. Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia. Eur J Cancer 2004; 40: 579–584
   PubMed Web of Science ®Google Scholar
• Reynolds P, Von Behren J, Elkin E P. Birth characteristics and leukemia in young children. Am J Epidemiol 2002; 155: 603–613
   PubMed Web of Science ®Google Scholar
• Lei U, Wohlfahrt J, Hjalgrim H, Hjalgrim L L, Simonsen H, Melbye M. Neonatal level of thyroid-stimulating hormone and acute childhood leukemia. Int J Cancer 2000; 88: 486–488
   PubMedGoogle Scholar
• Lander E S, Schork N J. Genetic dissection of complex traits. Science 1994; 265: 2037–2048
   PubMed Web of Science ®Google Scholar
• Rothman N, Wacholder S, Caporaso N E, Garcia-Closas M, Buetow K, Fraumeni J F, Jr. The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta 2001; 1471: C1–C10
   PubMed Web of Science ®Google Scholar
• Caporaso N E. Why have we failed to find the low penetrance genetic constituents of common cancers?. Cancer Epidemiol Biomarkers Prev 2002; 11: 1544–1549
   PubMed Web of Science ®Google Scholar
• O'Sullivan J J, Pearce M S, Parker L. Parental recall of birth weight: how accurate is it?. Arch Dis Child 2000; 82: 202–203
   PubMed Web of Science ®Google Scholar
• Buka S L, Goldstein J M, Seidman L J, Tsuang M T. Maternal recall of pregnancy history: accuracy and bias in schizophrenia research. Schizophr Bull 2000; 26: 335–350
   PubMed Web of Science ®Google Scholar
• Buka S L, Goldstein J M, Spartos E, Tsuang M T. The retrospective measurement of prenatal and perinatal events: accuracy of maternal recall. Schizophr Res 2004; 71: 417–426
   PubMed Web of Science ®Google Scholar
• Hjalgrim L L, Westergaard T, Rostgaard K, Schmiegelow K, Melbye M, Hjalgrim H, Engels E A. Birth weight as a risk factor for childhood leukemia: a meta-analysis of 18 epidemiologic studies. Am J Epidemiol 2003; 158: 724–735
   PubMed Web of Science ®Google Scholar
• MacMahon B, Newill V A. Birth characteristics of children dying of malignant neoplasms. J Natl Cancer Inst 1962; 28: 231–244
   PubMedGoogle Scholar
• Fasal E, Jackson E W, Klauber M R. Birth characteristics and leukemia in childhood. J Natl Cancer Inst 1971; 47: 501–509
   PubMedGoogle Scholar
• Daling J R, Starzyk P, Olshan A F, Weiss N S. Birth weight and the incidence of childhood cancer. J Natl Cancer Inst 1984; 72: 1039–1041
   PubMedGoogle Scholar
• Shaw G, Lavey R, Jackson R, Austin D. Association of childhood leukemia with maternal age, birth order, and paternal occupation. A case-control study. Am J Epidemiol 1984; 119: 788–795
   PubMed Web of Science ®Google Scholar
• Robison L L, Codd M, Gunderson P, Neglia J P, Smithson W A, King F L. Birth weight as a risk factor for childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1987; 4: 63–72
   PubMed Web of Science ®Google Scholar
• Shu X O, Gao Y T, Brinton L A, Linet M S, Tu J T, Zheng W, Fraumeni J F, Jr. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988; 62: 635–644
   PubMed Web of Science ®Google Scholar
• Shu X O, Jin F, Linet M S, Zheng W, Clemens J, Mills J, Gao Y T. Diagnostic X-ray and ultrasound exposure and risk of childhood cancer. Br J Cancer 1994; 70: 531–536
   PubMed Web of Science ®Google Scholar
• Savitz D A, Ananth C V. Birth characteristics of childhood cancer cases, controls, and their siblings. Pediatr Hematol Oncol 1994; 11: 587–599
   PubMed Web of Science ®Google Scholar
• Cnattingius S, Zack M M, Ekbom A, Gunnarskog J, Kreuger A, Linet M, Adami H O. Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 1995; 87: 908–914
   PubMed Web of Science ®Google Scholar
• Roman E, Ansell P, Bull D. Leukaemia and non-Hodgkin's lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease?. Br J Cancer 1997; 76: 406–415
   PubMed Web of Science ®Google Scholar
• Petridou E, Trichopoulos D, Kalapothaki V, Pourtsidis A, Kogevinas M, Kalmanti M, Koliouskas D, Kosmidis H, Panagiotou J P, Piperopoulou F, Tzortzatou F. The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer 1997; 76: 1241–1247
   PubMed Web of Science ®Google Scholar
• Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 1999; 28: 631–639
   PubMed Web of Science ®Google Scholar
• McKinney P A, Juszczak E, Findlay E, Smith K, Thomson C S. Pre-and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Br J Cancer 1999; 80: 1844–1851
   PubMed Web of Science ®Google Scholar
• Suminoe A, Matsuzaki A, Kinukawa N, Inamitsu T, Tajiri T, Suita S, Hara T. Rapid somatic growth after birth in children with neuroblastoma: a survey of 1718 patients with childhood cancer in Kyushu-Okinawa district. J Pediatr 1999; 134: 178–184
   PubMedGoogle Scholar
• Shu X O, Linet M S, Steinbuch M, Wen W Q, Buckley J D, Neglia J P, Potter J D, Reaman G H, Robison L L. Breast-feeding and risk of childhood acute leukemia. J Natl Cancer Inst 1999; 91: 1765–1772
   PubMed Web of Science ®Google Scholar
• Ou S X, Han D, Severson R K, Chen Z, Neglia J P, Reaman G H, Buckley J D, Robison L L. Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 2002; 13: 15–25
   PubMedGoogle Scholar
• Hjalgrim L L, Rostgaard K, Hjalgrim H, Westergaard T, Thomassen H, Forestier E, Gustafsson G, Kristinsson J, Melbye M, Schmiegelow K. Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland. J Natl Cancer Inst 2004; 96: 1549–1556
   PubMed Web of Science ®Google Scholar
• Ananth C V, Wen S W. Trends in fetal growth among singleton gestations in the United States and Canada, 1985 through 1998. Semin Perinatol 2002; 26: 260–267
   PubMed Web of Science ®Google Scholar
• Ross J A. High birth weight and cancer: evidence and implications. Cancer Epidemiol Biomarkers Prev 2006; 15: 1–2
   PubMed Web of Science ®Google Scholar
• Boulet S L, Alexander G R, Salihu H M, Pass M. Macrosomic births in the United States: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol 2003; 188: 1372–1378
   PubMed Web of Science ®Google Scholar
• Stotland N E, Hopkins L M, Caughey A B. Gestational weight gain, macrosomia, and risk of cesarean birth in nondiabetic nulliparas. Obstet Gynecol 2004; 104: 671–677
   PubMed Web of Science ®Google Scholar
• Surkan P J, Hsieh C C, Johansson A L, Dickman P W, Cnattingius S. Reasons for increasing trends in large for gestational age births. Obstet Gynecol 2004; 104: 720–726
   PubMed Web of Science ®Google Scholar
• Ricart W, Lopez J, Mozas J, Pericot A, Sancho M A, Gonzalez N, Balsells M, Luna R, Cortazar A, Navarro P, Ramirez O, Flandez B, Pallardo L F, Hernandez-Mijas A, Ampudia J, Fernandez-Real J M, Corcoy R. Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia. Diabetologia 2005; 48: 1736–1742
   PubMed Web of Science ®Google Scholar
• Olivecrona H, Hilding A, Ekstrom C, Barle H, Nyberg B, Moller C, Delhanty P J, Baxter R C, Angelin B, Ekstrom T J, Tally M. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans. J Clin Endocrinol Metab 1999; 84: 553–560
   PubMedGoogle Scholar
• Watson A J, Watson P H, Arcellana-Panlilio M, Warnes D, Walker S K, Schultz G A, Armstrong D T, Seamark R F. A growth factor phenotype map for ovine preimplantation development. Biol Reprod 1994; 50: 725–733
   PubMed Web of Science ®Google Scholar
• Fowden A L, Li J, Forhead A J. Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance?. Proc Nutr Soc 1998; 57: 113–122
   PubMed Web of Science ®Google Scholar
• Hill D J, Petrik J, Arany E. Growth factors and the regulation of fetal growth. Diabetes Care 1998; 21: B60–B69, Suppl 2
   Google Scholar
• Fowden A L. The insulin-like growth factors and feto-placental growth. Placenta 2003; 24: 803–812
   PubMed Web of Science ®Google Scholar
• Skalkidou A, Petridou E, Papathoma E, Salvanos H, Kedikoglou S, Chrousos G, Trichopoulos D. Determinants and consequences of major insulin-like growth factor components among full-term healthy neonates. Cancer Epidemiol Biomarkers Prev 2003; 12: 860–865
   PubMedGoogle Scholar
• Blatt J. IGF1 and leukemia. Pediatr Hematol Oncol 2000; 17: 199–201
   PubMed Web of Science ®Google Scholar
• Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000; 183: 1–9
   PubMed Web of Science ®Google Scholar
• Yang S W, Kim S Y. The relationship of the levels of leptin, insulin-like growth factor-I and insulin in cord blood with birth size, ponderal index, and gender difference. J Pediatr Endocrinol Metab 2000; 13: 289–296
   PubMedGoogle Scholar
• Skalkidou A, Petridou E, Papathom E, Salvanos H, Chrousos G, Trichopoulos D. Birth size and neonatal levels of major components of the IGF system: implications for later risk of cancer. J Pediatr Endocrinol Metab 2002; 15: 1479–1486
   PubMedGoogle Scholar
• Vatten L J, Nilsen S T, Odegard R A, Romundstad P R, Austgulen R. Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics 2002; 109: 1131–1135
   PubMed Web of Science ®Google Scholar
• Ohnishi Y, Yamashiro C, Yanagihara T, Hata T. Hepatocyte growth factor concentration in the early second-trimester amniotic fluid does not predict fetal growth at birth. Hum Reprod 1999; 14: 2625–2628
   PubMedGoogle Scholar
• Verhaeghe J, Coopmans W, van Herck E, van Schoubroeck D, Deprest J A, Witters I. IGF-I, IGF-II, IGF binding protein 1, and C-peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth. Pediatr Res 1999; 46: 101–108
   PubMedGoogle Scholar
• Tisi D K, Liu X J, Wykes L J, Skinner C D, Koski K G. Insulin-like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated with infant birth weight. J Nutr 2005; 135: 1667–1672
   PubMed Web of Science ®Google Scholar
• Wilpshaar J, Joekes E C, Lim F T, Van Leeuwen G A, Van den Boogaard P J, Kanhai H H, Willemze R, Falkenburg J H. Magnetic resonance imaging of fetal bone marrow for quantitative definition of the human fetal stem cell compartment. Blood 2002; 100: 451–457
   PubMedGoogle Scholar
• Baik I, Devito W J, Ballen K, Becker P S, Okulicz W, Liu Q, Delpapa E, Lagiou P, Sturgeon S, Trichopoulos D, Quesenberry P J, Hsieh C C. Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer. Cancer Res 2005; 65: 358–363
   PubMedGoogle Scholar
• Grimberg A. Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther 2003; 2: 630–635
   PubMed Web of Science ®Google Scholar
• Ross J A, Perentesis J P, Robison L L, Davies S M. Big babies and infant leukemia: a role for insulin-like growth factor-1?. Cancer Causes Control 1996; 7: 553–539
   PubMed Web of Science ®Google Scholar
• Ogilvy-Stuart A L, Gleeson H. Cancer risk following growth hormone use in childhood: implications for current practice. Drug Saf 2004; 27: 369–382
   PubMed Web of Science ®Google Scholar
• Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman H L, Kajstura J, Rubin R, Zoltick P, Baserga R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 1995; 55: 2463–2469
   PubMed Web of Science ®Google Scholar
• Prisco M, Hongo A, Rizzo M G, Sacchi A, Baserga R. The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal. Mol Cell Biol 1997; 17: 1084–1092
   PubMedGoogle Scholar
• D'Ambrosio C, Valentinis B, Prisco M, Reiss K, Rubini M, Baserga R. Protective effect of the insulin-like growth factor I receptor on apoptosis induced by okadaic acid. Cancer Res 1997; 57: 3264–3271
   PubMedGoogle Scholar
• Grimberg A. P53 and IGFBP-3: apoptosis and cancer protection. Mol Genet Metab 2000; 70: 85–98
   PubMed Web of Science ®Google Scholar
• Nieto-Diaz A, Villar J, Matorras-Weinig R, Valenzuela-Ruiz P. Intrauterine growth retardation at term: association between anthropometric and endocrine parameters. Acta Obstet Gynecol Scand 1996; 75: 127–131
   PubMed Web of Science ®Google Scholar
• Anselmo J, Cao D, Karrison T, Weiss R E, Refetoff S. Fetal loss associated with excess thyroid hormone exposure. JAMA 2004; 292: 691–695
   PubMed Web of Science ®Google Scholar
• Ross J A, Potter J D, Robison L L. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 1994; 86: 1678–1680
   PubMed Web of Science ®Google Scholar
• Schutt B S, Weber K, Elmlinger M W, Ranke M B. Measuring IGF-I, IGFBP-2 and IGFBP-3 from dried blood spots on filter paper is not only practical but also reliable. Growth Horm IGF Res 2003; 13: 75–80
   PubMedGoogle Scholar
• Vaessen N, Janssen J A, Heutink P, Hofman A, Lamberts S W, Oostra B A, Pols H A, van Duijn C M. Association between genetic variation in the gene for insulin-like growth factor-I and low birth weight. Lancet 2002; 359: 1036–1037
   PubMed Web of Science ®Google Scholar
• Frayling T M, Hattersley A T, McCarthy A, Holly J, Mitchell S M, Gloyn A L, Owen K, Davies D, Smith G D, Ben-Shlomo Y. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 2002; 51: 2313–2316
   PubMed Web of Science ®Google Scholar
• Johnston L B, Dahlgren J, Leger J, Gelander L, Savage M O, Czernichow P, Wikland K A, Clark A J. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre-and postnatal growth in two European small for gestational age populations. J Clin Endocrinol Metab 2003; 88: 4805–4810
   PubMed Web of Science ®Google Scholar
• Pui C H, Ribeiro R C, Hancock M L, Rivera G K, Evans W E, Raimondi S C, Head D R, Behm F G, Mahmoud M H, Sandlund J T, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991; 325: 1682–1687
   PubMed Web of Science ®Google Scholar
• Kumar L. Epipodophyllotoxins and secondary leukaemia. Lancet 1993; 342: 819–820
   PubMed Web of Science ®Google Scholar
• Gewirtz D A. Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?. Biochem Pharmacol 1991; 42: 2253–2258
   PubMed Web of Science ®Google Scholar
• Zandvliet D W, Hanby A M, Austin C A, Marsh K L, Clark I B, Wright N A, Poulsom R. Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisation. Biochim Biophys Acta 1996; 1307: 239–247
   PubMedGoogle Scholar
• Long B H. Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16). Semin Oncol 1992; 19: 3–19
   PubMedGoogle Scholar
• Ross J A, Potter J D, Robison L L. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst 1994; 86: 1678–1680
   PubMed Web of Science ®Google Scholar
• Ross J A, Potter J D, Reaman G H, Pendergrass T W, Robison L L. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control 1996; 7: 581–590
   PubMed Web of Science ®Google Scholar
• Ross J A, Kasum C M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22: 19–34
   PubMed Web of Science ®Google Scholar
• Strissel P L, Strick R. Multiple effects of bioflavonoids on gene regulation, cell proliferation and apoptosis: natural compounds move into the lime light of cancer research. Leuk Res 2005; 29: 859–861
   PubMedGoogle Scholar
• Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342: 1209–1210
   PubMed Web of Science ®Google Scholar
• Xu X, Wang H J, Murphy P A, Cook L, Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994; 124: 825–832
   PubMed Web of Science ®Google Scholar
• Hollman P C, de Vries J H, van Leeuwen S D, Mengelers M J, Katan M B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995; 62: 1276–1282
   PubMed Web of Science ®Google Scholar
• Xu X, Harris K S, Wang H J, Murphy P A, Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995; 125: 2307–2315
   PubMed Web of Science ®Google Scholar
• Hollman P C, van Trijp J M, Buysman M N, van der Gaag M S, Mengelers M J, de Vries J H, Katan M B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 1997; 418: 152–156
   PubMed Web of Science ®Google Scholar
• Setchell K D, Zimmer-Nechemias L, Cai J, Heubi J E. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 1997; 350: 23–27
   PubMed Web of Science ®Google Scholar
• de Vries J H, Hollman P C, Meyboom S, Buysman M N, Zock P L, van Staveren W A, Katan M B. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am J Clin Nutr 1998; 68: 60–65
   PubMed Web of Science ®Google Scholar
• Hollman P C, Katan M B. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 1999; 37: 937–942
   PubMed Web of Science ®Google Scholar
• Felgines C, Texier O, Morand C, Manach C, Scalbert A, Regerat F, Remesy C. Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol 2000; 279: G1148–G1154
   PubMed Web of Science ®Google Scholar
• Moon J H, Nakata R, Oshima S, Inakuma T, Terao J. Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women. Am J Physiol Regul Integr Comp Physiol 2000; 279: R461–R467
   PubMed Web of Science ®Google Scholar
• Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000; 130: 2073S–2085S
   PubMed Web of Science ®Google Scholar
• de Vries J H, Hollman P C, van Amersfoort I, Olthof M R, Katan M B. Red wine is a poor source of bioavailable flavonols in men. J Nutr 2001; 131: 745–748
   PubMed Web of Science ®Google Scholar
• Schroder-van d er, Elst J P, van der Heide D, Rokos H, Morreale de Escobar G, Kohrle J. Synthetic flavonoids cross the placenta in the rat and are found in fetal brain. Am J Physiol 1998; 274: E253–E256
   Google Scholar
• Strick R, Strissel P L, Borgers S, Smith S L, Rowley J D. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA 2000; 97: 4790–4795
   PubMed Web of Science ®Google Scholar
• Michael McClain R, Wolz E, Davidovich A, Bausch J. Genetic toxicity studies with genistein. Food Chem Toxicol 2006; 44: 42–55
   PubMed Web of Science ®Google Scholar
• Moneypenny C G, Shao J, Song Y, Gallagher E P. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells. Carcinogenesis 2006; 27: 874–881
   PubMedGoogle Scholar
• Ross J A, Potter J D, Reaman G H, Pendergrass T W, Robison L L. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control 1996; 7: 581–590
   PubMed Web of Science ®Google Scholar
• De Long M J, Prochaska H J, Talalay P. Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens. Proc Natl Acad Sci USA 1986; 83: 787–791
   PubMed Web of Science ®Google Scholar
• Uda Y, Price K R, Williamson G, Rhodes M J. Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids. Cancer Lett 1997; 120: 213–216
   PubMed Web of Science ®Google Scholar
• Wiemels J L, Pagnamenta A, Taylor G M, Eden O B, Alexander F E, Greaves M F. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Research. 1999; 59: 4095–4099
   PubMed Web of Science ®Google Scholar
• Smith M T, Wang Y, Skibola C F, Slater D J, Lo Nigro L, Nowell P C, Lange B J, Felix C A. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 2002; 100: 4590–4593
   PubMed Web of Science ®Google Scholar
• Kracht T, Schrappe M, Strehl S, Reiter A, Elsner H A, Trka J, Cario G, Viehmann S, Harbott J, Borkhardt A, Metzler M, Langer T, Repp R, Marschalek R, Welte K, Haas O A, Stanulla M. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. Haematologica 2004; 89: 1492–1497
   PubMedGoogle Scholar
• Lanciotti M, Dufour C, Corral L, DiMichele P, Pigullo S, De Rossi G, Basso G, Leszl A, Luciani M, Lo Nigro L, Micalizzi C, Valsecchi M G, Biondi A, Haupt R. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Leukemia 2005; 19: 214–216
   PubMedGoogle Scholar
• Duthie S J. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 1999; 55: 578–92
   PubMed Web of Science ®Google Scholar
• Thompson J R, Gerald P F, Willoughby M L, Armstrong B K. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet 2001; 358: 1935–1940
   PubMed Web of Science ®Google Scholar
• Jensen C D, Block G, Buffler P, Ma X, Selvin S, Month S. Maternal dietary risk factors in childhood acute lymphoblastic leukemia (United States). Cancer Causes Control 2004; 15: 559–570
   PubMed Web of Science ®Google Scholar
• Wiemels J L, Smith R N, Taylor G M, Eden O B, Alexander F E, Greaves M F. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001; 98: 4004–4009
   PubMed Web of Science ®Google Scholar
• Franco R F, Simoes B P, Tone L G, Gabellini S M, Zago M A, Falcao R P. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 2001; 115: 616–618
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, Sinnett D. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004; 103: 252–257
   PubMed Web of Science ®Google Scholar
• French A E, Grant R, Weitzman S, Ray J G, Vermeulen M J, Sung L, Greenberg M, Koren G. Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 2003; 74: 288–294
   PubMed Web of Science ®Google Scholar
• Kwan M L, Block G, Selvin S, Month S, Buffler P A. Food consumption by children and the risk of childhood acute leukemia. Am J Epidemiol 2004; 160: 1098–1107
   PubMed Web of Science ®Google Scholar
• Petridou E, Ntouvelis E, Dessypris N, Terzidis A, Trichopoulos D. Maternal diet and acute lymphoblastic leukemia in young children. Cancer Epidemiol Biomarkers Prev 2005; 14: 1935–1939
   PubMed Web of Science ®Google Scholar
• Gurney J G, Smith M A, Olshan A F, Hecht S S, Kasum C M. Clues to the etiology of childhood brain cancer: N-nitroso compounds, polyomaviruses, and other factors of interest. Cancer Invest 2001; 19: 630–640
   PubMed Web of Science ®Google Scholar
• Sarasua S, Savitz D A. Cured and broiled meat consumption in relation to childhood cancer: Denver, Colorado (United States). Cancer Causes Control 1994; 5: 141–148
   PubMed Web of Science ®Google Scholar
• Peters J M, Preston-Martin S, London S J, Bowman J D, Buckley J D, Thomas D C. Processed meats and risk of childhood leukemia (California, USA). Cancer Causes Control 1994; 5: 195–202
   PubMed Web of Science ®Google Scholar
• Wen W, Shu X O, Potter J D, Severson R K, Buckley J D, Reaman G H, Robison L L. Parental medication use and risk of childhood acute lymphoblastic leukemia. Cancer 2002; 95: 1786–1794
   PubMed Web of Science ®Google Scholar
• Ross J A, Blair C K, Olshan A F, Robison L L, Smith F O, Heerema N A, Roesler M. Periconceptional vitamin use and leukemia risk in children with Down syndrome: a Children's Oncology Group study. Cancer 2005; 104: 405–410
   PubMedGoogle Scholar
• Omenn G S, Goodman G E, Thornquist M D, Balmes J, Cullen M R, Glass A, Keogh J P, Meyskens F L, Jr., Valanis B, Williams J H, Jr., Barnhart S, Cherniack M G, Brodkin C A, Hammar S. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996; 88: 1550–1559
   PubMed Web of Science ®Google Scholar
• Chen D, Daniel K G, Chen M S, Kuhn D J, Landis-Piwowar K R, Dou Q P. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol 2005; 69: 1421–1432
   PubMed Web of Science ®Google Scholar
• Matsui J, Kiyokawa N, Takenouchi H, Taguchi T, Suzuki K, Shiozawa Y, Saito M, Tang W R, Katagiri Y U, Okita H, Fujimoto J. Dietary bioflavonoids induce apoptosis in human leukemia cells. Leuk Res 2005; 29: 573–581
   PubMed Web of Science ®Google Scholar
• Chow L M, Chui C H, Tang J C, Lau F Y, Yau M Y, Cheng G Y, Wong R S, Lai P B, Leung T W, Teo I T, Cheung F, Guo D, Chan A S. Anti-angiogenic potential of Gleditsia sinensis fruit extract. Int J Mol Med 2003; 12: 269–273
   PubMedGoogle Scholar
• Chen M S, Chen D, Dou Q P. Inhibition of proteasome activity by various fruits and vegetables is associated with cancer cell death. In Vivo 2004; 18: 73–80
   PubMedGoogle Scholar
• Graham S. Epidemiology of retinoids and cancer. J Natl Cancer Inst 1984; 73: 1423–1428
   PubMedGoogle Scholar
• Wolterbeek A P, Roggeband R, van Moorsel C J, Baan R A, Koeman J H, Feron V J, Rutten A A. Vitamin A and beta-carotene influence the level of benzo[a]pyrene-induced DNA adducts and DNA-repair activities in hamster tracheal epithelium in organ culture. Cancer Lett 1995; 91: 205–214
   PubMedGoogle Scholar
• Fillion L, Collins A, Southon S. Beta-carotene enhances the recovery of lymphocytes from oxidative DNA damage. Acta Biochim Pol 1998; 45: 183–190
   PubMed Web of Science ®Google Scholar
• Torbergsen A C, Collins A R. Recovery of human lymphocytes from oxidative DNA damage; the apparent enhancement of DNA repair by carotenoids is probably simply an antioxidant effect. Eur J Nutr 2000; 39: 80–85
   PubMed Web of Science ®Google Scholar
• Astley S B, Elliott R M, Archer D B, Southon S. Increased cellular carotenoid levels reduce the persistence of DNA single-strand breaks after oxidative challenge. Nutr Cancer 2002; 43: 202–213
   PubMed Web of Science ®Google Scholar
• Padayatty S J, Katz A, Wang Y, Eck P, Kwon O, Lee J H, Chen S, Corpe C, Dutta A, Dutta S K, Levine M. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr 2003; 22: 18–35
   PubMed Web of Science ®Google Scholar
• Tatman D, Mo H. Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells. Cancer Lett 2002; 175: 129–139
   PubMed Web of Science ®Google Scholar
• Jansson B. Dietary, total body, and intracellular potassium-to-sodium ratios and their influence on cancer. Cancer Detect Prev 1990; 14: 563–565
   PubMedGoogle Scholar
• Jansson B. Potassium, sodium, and cancer: a review. J Environ Pathol Toxicol Oncol 1996; 15: 65–73
   PubMedGoogle Scholar
• Thompson B, Demark-Wahnefried W, Taylor G, McClelland J W, Stables G, Havas S, Feng Z, Topor M, Heimendinger J, Reynolds K D, Cohen N. Baseline fruit and vegetable intake among adults in seven 5 a day study centers located in diverse geographic areas. J Am Diet Assoc 1999; 99: 1241–1248
   PubMed Web of Science ®Google Scholar
• Li R, Serdula M, Bland S, Mokdad A, Bowman B, Nelson D. Trends in fruit and vegetable consumption among adults in 16 US states: Behavioral Risk Factor Surveillance System, 1990–1996. Am J Public Health 2000; 90: 777–781
   PubMed Web of Science ®Google Scholar
• Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003; 78: 559S–569S
   PubMed Web of Science ®Google Scholar
• Kristal A R, Peters U, Potter J D. Is it time to abandon the food frequency questionnaire?. Cancer Epidemiol Biomarkers Prev 2005; 14: 2826–2828
   PubMed Web of Science ®Google Scholar